Elsevier

Biomaterials

Volume 30, Issue 2, January 2009, Pages 196-207
Biomaterials

Hydrogel based on interpenetrating polymer networks of dextran and gelatin for vascular tissue engineering

https://doi.org/10.1016/j.biomaterials.2008.09.041Get rights and content

Abstract

Hydrogel networks are highly desirable as three-dimensional (3-D) tissue engineering scaffolds for cell encapsulation due to the high water content and ability to mimick the native extracellular matrix. However, their application is limited by their nanometer-scale mesh size, which restricts the spreading and proliferation of encapsulated cells, and their poor mechanical properties. This study seeks to address both limitations through application of a novel cell-encapsulating hydrogel family based on the interpenetrating polymer network (IPN) of gelatin and dextran bifunctionalized with methacrylate (MA) and aldehyde (AD) (Dex–MA–AD). The chemical structure of the synthesized Dex–MA–AD was verified by 1H-NMR and the degrees of substitution of MA and AD were found to be 14 and 13.9 ± 1.3 respectively. The water contents in all these hydrogels were approximately 80%. Addition of 40 mg/ml to 60 mg/ml gelatin to neat Dex–MA–AD increased the compressive modulus from 15.4 ± 3.0 kPa to around 51.9 ± 0.1 kPa (about 3.4-fold). Further, our IPN hydrogels have higher dynamic storage moduli (i.e. on the order of 104 Pa) than polyethylene glycol-based hydrogels (around102–103 Pa) commonly used for smooth muscle cells (SMCs) encapsulation. Our dextran-based IPN hydrogels not only supported endothelial cells (ECs) adhesion and spreading on the surface, but also allowed encapsulated SMCs to proliferate and spread in the bulk interior of the hydrogel. These IPN hydrogels appear promising as 3-D scaffolds for vascular tissue engineering.

Introduction

Hydrogel networks are widely used as three-dimensional (3-D) soft tissue engineering scaffolds to encapsulate cells due to their high water content and physical properties emulating the native extracellular matrix (ECM) [1], [2], [3]. When encapsulated inside hydrogels, cells requiring extensive cell spreading, such as fibroblasts and smooth muscle cells (SMCs), unlike chondrocytes, show a round morphology and delayed proliferation, migration and matrix production due to the hydrogel initial nanometer-scale mesh size [4], [5], [6], [7].

Degradable hydrogels have been investigated for generating space in order to allow cells to spread and migrate as the gel network degrades. For hydrolytically degradable hydrogels, synchronization of the rate of degradation with cellular growth and matrix accumulation to match tissue evolution is not trivial [2], [5], [8], [9], [10]. Enzymatically labile hydrogels that degrade by cell-secreted or exogenously applied enzymes is an alternative family of degradable hydrogels which has been shown to support 3-D cell spreading [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26]. Many of these hydrogels are based on peptide/protein modified polyethylene glycol (PEG), which have been shown to support spreading, migration and cell–cell contacts of fibroblasts, SMCs and mesenchymal stem cells (MSCs) within them and promote dorsal root ganglion cell outgrowth and bone formation [12], [19], [20], [26]. The pericellularly localized degradation due to the protein components enables tuning of the degradation rate to closely match the tissue formation rate [23]. However, many of these PEG-based hydrogels are quite soft with elastic moduli on the order of 102–103 Pa [12], [22], [24], [25], making them difficult to handle. Besides, soft gels are unable to support high level of cell-generated tension required to sustain stress fibers and focal adhesion, which would eventually influence cell function and tissue formation [24].

Dextran, a natural hydrophilic degradable polysaccharide, is an alternative to PEG for hydrogel formation [27], [28], [29], [30], [31], [32], [33], [34], [35]. Although it is resistant to protein adsorption and cell adhesion [36], dextran possesses abundant pendant hydroxyl functional groups making it amenable to chemical modification [34], [37]. It has been used as two-dimensional (2-D) or porous soft tissue engineering scaffold and in drug-delivery [33], [35], [38]. RGD modified dextran has been used for encapsulation of aggregates (rather than individual) of human embryonic stem cells (hESCs) by Langer's group [31]. Although enhanced vascular differentiation was reported, cellular proliferation was not observed. Rather than using adhesive peptide, gelatin which has good biodegradability and low level of immunogenicity and cytotoxicity [39], can also be incorporated into dextran hydrogel [28], [29], [40].

In this paper, we have synthesized a methacrylate- and aldehyde-bifunctionalized dextran (Dex–MA–AD) (Scheme 1) and demonstrated a new cell-encapsulating hydrogel family based on the interpenetrating network of Dex–MA–AD and gelatin (Scheme 2). The hydrogel is formed by ultraviolet (UV)-crosslinking between pendant methacrylate groups on Dex–MA–AD and Schiff base reaction between Dex–MA–AD and gelatin. The synthesized Dex–MA–AD was characterized by 1H-NMR. The physical properties (i.e. sol content, compressive and dynamic mechanical properties and swelling ratio) were also measured. Adhesion and spreading of ECs in 2-D culture and spreading and proliferation of SMCs in 3-D culture were observed with these hydrogels. Also, this hydrogel possesses relatively high elastic modulus (on the order of 104 Pa) making it desirable for vascular tissue engineering.

Section snippets

Materials

Dextran (from Leuconostoc mesenteroides, average mol wt. 400,000–500,000 Dalton, Mn), gelatin type B (from bovine skin), dimethyl sulfoxide (DMSO), 4-dimethylaminopyridine (DMAP), deuterium oxide, glycidyl methacrylate (GMA), phosphate buffered saline and sodium periodate were obtained from Sigma–Aldrich. 4-(2-hydroxyethoxy) phenyl-(2-hydroxy-2-propyl) ketone (Irgacure 2959) was purchased from Ciba (Singapore). All reagents were used as received. Deionized (DI) water was produced with a

Synthesis of bifunctional dextran

Dex–MA–AD was synthesized by coupling GMA to dextran followed by oxidation of Dex–MA with sodium periodate, as shown in Scheme 1. The 1H-NMR spectrum of dextran (Fig. 1a) confirms its structure [41], [42], [43]. The 1H-NMR spectrum for Dex–MA–AD (Fig. 1b) shows, in addition to the distinctive resonance peaks of pristine dextran, the methyl protons from the methacryloyl group (position 7) at about δ 1.85 ppm and the protons from the double bond (position 8) at δ 5.65 ppm and δ 6.14 ppm; there is no

Discussion

We have synthesized and characterized an IPN hydrogel series based on methacrylate and aldehyde-bifunctionalized dextran (Dex–MA–AD) and gelatin. The methacrylate groups on Dex–MA–AD were used for UV crosslinking and the aldehyde groups enabled the incorporation of chemically linked gelatin. We chose a low extent of dextran oxidation – DS of aldehyde 13.9 ± 1.3 – since increasing the density of aldehyde groups on dextran decreases its solubility but hastens the formation of Schiff base, making

Conclusion

We have demonstrated a new class of gelatin-bonded dextran-based hydrogel with relatively high modulus that is also suitable for 3-D encapsulation of SMCs and 2-D culture of ECs. Using bifunctional dextran modified with methacrylate and aldehyde groups mixed with gelatin, UV crosslinked hydrogels encapsulating vascular SMCs were fabricated. The Dex–MA–AD component imparted to the hydrogels elastic properties that are superior to commonly reported PEG-based hydrogels. The incorporation of

Acknowledgements

This project was supported by a Singapore Ministry of Education Tier 2 Grant (M45120007). Liu YX was supported by an NTU PhD scholarship.

References (56)

  • M. Gonen-Wadmany et al.

    Protein–polymer conjugates for forming photopolymerizable biomimetic hydrogels for tissue engineering

    Biomaterials

    (2007)
  • G.P. Raeber et al.

    Mechanisms of 3-D migration and matrix remodeling of fibroblasts within artificial ECMs

    Acta Biomater

    (2007)
  • K. Shapira-Schweitzer et al.

    Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial

    Acta Biomater

    (2007)
  • D. Dikovsky et al.

    Defining the role of matrix compliance and proteolysis in three-dimensional cell spreading and remodeling

    Biophys J

    (2008)
  • S.R. Peyton et al.

    The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system

    Biomaterials

    (2008)
  • G.P. Raeber et al.

    Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration

    Biophys J

    (2005)
  • F.M. Chen et al.

    Novel glycidyl methacrylated dextran (Dex–GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics

    J Controlled Release

    (2007)
  • F.M. Chen et al.

    Periodontal regeneration using novel glycidyl methacrylated dextran (Dex–GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins

    J Controlled Release

    (2007)
  • L.S. Ferreira et al.

    Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells

    Biomaterials

    (2007)
  • T. Ito et al.

    Dextran-based in situ cross-linked injectable hydrogels to prevent peritoneal adhesions

    Biomaterials

    (2007)
  • S.G. Levesque et al.

    Synthesis of cell-adhesive dextran hydrogels and macroporous scaffolds

    Biomaterials

    (2006)
  • S. Moller et al.

    Dextran and hyaluronan methacrylate based hydrogels as matrices for soft tissue reconstruction

    Biomol Eng

    (2007)
  • S.P. Massia et al.

    Surface-immobilized dextran limits cell adhesion and spreading

    Biomaterials

    (2000)
  • R. Mehvar

    Dextrans for targeted and sustained delivery of therapeutic and imaging agents

    J Controlled Release

    (2000)
  • S. Young et al.

    Gelatin as a delivery vehicle for the controlled release of bioactive molecules

    J Controlled Release

    (2005)
  • J.D. Kosmala et al.

    Preparation of interpenetrating networks of gelatin and dextran as degradable biomaterials

    Biomaterials

    (2000)
  • S.G. Levesque et al.

    Macroporous interconnected dextran scaffolds of controlled porosity for tissue-engineering applications

    Biomaterials

    (2005)
  • J. Maia et al.

    Synthesis and characterization of new injectable and degradable dextran-based hydrogels

    Polymer

    (2005)
  • Cited by (233)

    View all citing articles on Scopus
    View full text